Medical Seminar

[MeS05] Medical Seminar 5　AML treatment strategy Up to date

Thu. Feb 17, 2022 12:15 PM - 1:05 PM Room 7 (Room E, 1F, Kyoto International Conference Center)

Chair：Itaru Matsumura（Departments of Hematology and Rheumatology, Faculty of Medicine, Kindai University Hospital）

[MeS06] Medical Seminar 6　Advanced strategy of cancer genome medicine ～in house NGS Lab～

Thu. Feb 17, 2022 12:15 PM - 1:05 PM Room 8 (Sakura, 1F, Kyoto International Conference Center)

Chair：Hiroshi Nishihara（Genome Unit, Keio Cancer Center, Keio University School of Medicine）

Sponsored by Illumina K.K. / Sysmex Corporation

Medical Seminar

[MeS07] Medical Seminar 7　Management of Advanced HCC in the Era of Atezolizumab-Bevacizumab: Current Evidence and Future Perspective

Thu. Feb 17, 2022 12:15 PM - 1:05 PM Room 9 (Swan, 1F, Kyoto International Conference Center)

Chair：Masafumi Ikeda（Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East）

Sponsored by CHUGAI PHARMACEUTICAL CO., LTD.

Medical Seminar

[MeS08] Medical Seminar 8　Abemaciclib use in Early Breast Cancer; Clinical Experience and Optimal Side Effect management
【SI】

Thu. Feb 17, 2022 12:15 PM - 1:05 PM Room 10 (Royal Room, 1F, The Prince Kyoto Takaragaike)

Chair：Shigehira Saji（Department of Medical Oncology, Fukushima Medical University）

[MeS09] Medical Seminar 9　Treatment options for relapsed and refractory multiple myeloma after lenalidomide-containing therapy

Thu. Feb 17, 2022 12:15 PM - 1:05 PM Room 11 and 12 (Prince Hall 1 and 2, B2F, The Prince Kyoto Takaragaike)

Chair：Shigeki Ito（Hematology and Oncology, Department of Internal Medicine, Iwate Medical University School of Medicine）

[MeS10] Medical Seminar 10　Neoadjuvant chemotherapy for HER2-positive breast cancer in the era of Residual disease-guided approach

Thu. Feb 17, 2022 12:15 PM - 1:05 PM Room 13 (Gold Room, B2F, The Prince Kyoto Takaragaike)

Chair：Koichiro Tsugawa（Division of Breast and Endocrine Surgery, Department of Surgery, St. Marianna University School of Medicine）

[ES01] Evening Seminar 1　Minimal Residual Disease Evolutionary Monitoring in Early Non-Small Cell Lung Cancer: Results from TRACERx

Thu. Feb 17, 2022 7:00 PM - 7:50 PM Room 1 (Main Hall, 1F, Kyoto International Conference Center)

Chair：Kazuto Nishio（Kindai University Faculty of Medicine Center of Genomics Kindai Life Science Research Institute）

[ES02] Evening Seminar 2　Incorporating checkpoint inhibitors into standard of care in advanced/metastatic gastric/GEJ cancer

Thu. Feb 17, 2022 7:00 PM - 7:50 PM Room 2 and 3 (Annex 1 and 2, 1F, Kyoto International Conference Center)

Chair：Kensei Yamaguchi（Gastroenterological Chemotherapy, Clinical Trial Planning and Management, Cancer Institute Hospital of Japanese Foundation for Cancer Research）

Sponsored by Bristol-Myers Squibb K.K. / ONO PHARMACEUTICAL CO., LTD.

Evening Seminar

[ES03] Evening Seminar 3　What's the current best choice of EGFR-TKI?～Discussion based on over 1,400 Japanese patients' real-world data～

Thu. Feb 17, 2022 7:00 PM - 7:50 PM Room 4 (Room A, 2F, Kyoto International Conference Center)

Chair：Miyako Satouchi（Department of Thoracic Oncology, Hyogo Cancer Center）

[ES04] Evening Seminar 4　How to improve outcomes in follicular lymphoma?
【SI】

Thu. Feb 17, 2022 7:00 PM - 7:50 PM Room 5 (Room B-1, 2F, Kyoto International Conference Center)

Chair：Masahiro Kizaki（Department of Hematology, Saitama Medical Center, Saitama Medical University）

Sponsored by CHUGAI PHARMACEUTICAL CO., LTD. / Nippon Shinyaku Co., Ltd.

Sessions

Thu. Feb 17, 2022